Major steps along the hepatitis C virus (HCV) care cascade in the study
population of incarcerated HCV-infected persons (n = 217), Vermont,
December 2018–June 2020. Data were obtained through a retrospective,
observational cohort study of all HCV-infected persons who were
imprisoned in Vermont during the study period. HCV infection determined
by detectable serum HCV RNA. At Step A, drop-off was 4 patients: 3 with
spontaneous HCV clearance and 1 from early release. At Step B, drop-off
was 84 patients: 38 from patient refusal, 23 from early release, 14 who
were detainers (ie, incarcerated persons awaiting sentencing), and 9
with spontaneous HCV clearance. At Step C, drop-off was 10 patients: 8
from early release and 2 from patient refusal. At Step D, drop-off was 8
patients: 6 from early release and 2 from patient refusal.
Abbreviations: DAA, direct-acting antiviral; SVR12, sustained virologic
response at 12 weeks post-treatment.